Table 1. In-Person and Telehealth Ambulatory Contacts for Continuously Enrolled Insured Study Cohort for March to June 2019 (Before the COVID-19 Pandemic) and March to June 2020 (During the COVID-19 Pandemic) Study Periodsa.
Variable | Participants, No. (%) (N = 36 568 010) | |
---|---|---|
March-June 2019 | March-June 2020 | |
Enrollees with ≥1 ambulatory contact | 18 942 276 (51.8) | 15 437 217 (42.2) |
Enrollees with ≥1 telehealth visit | 109 704 (0.3) | 4 977 415 (13.6) |
Ambulatory contacts per enrollee, No. | ||
Total b | 1.64 | 1.34 |
In-personb | 1.63 | 1.02 |
Telehealth | .01 | .32 |
Telehealth claims submitted in 2020 by modality | ||
Video supported | NA | 11 296 298 (74.4) |
Telephonic | NA | 1 391 618 (9.2) |
Email, chat, or other | NA | 502 837 (3.3) |
Unspecified | NA | 1 988 277 (13.1) |
Total | NA | 15 179 030 (100) |
Abbreviation: NA, not applicable.
Sample included persons continuously enrolled from March 1, 2019, through June 30, 2020, within private health insurance plans in the data files of Blue Health Intelligence, an affiliate of the Blue Cross and Blue Shield Association. See further details regarding sample selection in the text and eFigure 1 and eTable 1 in the Supplement.
All results consider only ambulatory encounters that are telehealth eligible. Total contacts include both in-person and telehealth visits. Contacts per enrollee include both users and nonusers. See text and eTable 3, eTable 4, and eTable 5 in the Supplement for further details.